OVERVIEW
Strengthen your processes and increase data-driven decision-making for faster study start-up.
Huge expenditures in clinical trials are presently guided by budgeting, planning, and resourcing using disconnected tools like Excel or other aged solutions. As a direct result, operational planning typically requires 6 months or more – delaying trial starts and missing opportunities to drive negotiated savings. The future of successful biopharma development will be underpinned by an increased use of more sophisticated technology and data. Here is where your new journey begins.
It [Clinical Maestro] wasn’t just a tool that helped forecast and budget. It helped drive conversation, and break down barriers, to challenge assumptions, and let people have the opportunity to defend their assumptions.
Mid size Biopharma
MARKET PROBLEM
Large Biopharma’s Complex Challenges in Trial Operations Management
Large biopharma companies face significant obstacles in clinical trial planning, budgeting, outsourcing, contract management, and vendor management, impacting efficiency, increasing costs, and delaying time-to-market for new therapies.
![Image](https://strategikon.com/wp-content/uploads/2024/10/Image-9.png)
Complex Financial Transactions
Inadequate tools and outdated methods make clinical trial planning and budgeting time-consuming and error-prone, leading to delays and inaccurate cost estimations that affect overall project timelines.
Inefficient Vendor Management
Managing preferred partner relationships and vendor portfolio performance can be overwhelming without streamlined sourcing processes and fit-for-purpose systems, causing delays, missed milestones, and lack of transparency into the relationship health.
Complex Contract Management
Managing a large portfolio of contracts with legacy tools creates user frustration and unscalable infrastructure.
Vendor Performance and Compliance Tracking Gaps
Monitoring vendor performance and ensuring compliance is challenging without robust tracking systems, increasing risks of misalignment with study goals, quality issues, and potential regulatory non-compliance.
BENEFITS
Transform Clinical Trial Operations with Fit For Purpose Solutions
Advanced technology streamlines clinical trial planning, budgeting, outsourcing, and vendor management, reducing costs, improving efficiency, and providing enhanced transparency for better operational control and faster study timelines.
![](/wp-content/uploads/2024/12/notebook-e1734592836484.png)
Streamlined Budgeting and Planning
PORTFOLIO enables precise operational planning, reducing manual effort by 75% and improving accuracy for clinical trial budgets and forecasts. You can leverage both market data and your own historical data trove.
![](/wp-content/uploads/2024/12/efficiency-1.png)
Accelerated Study Start-Up
Automated workflows and real-time insights reduce cycle times by over 25%, enabling faster trial initiation and smoother operational processes.
![](/wp-content/uploads/2024/12/dynamic-visualizations-2.png)
Enhanced Vendor Oversight
VISION centralizes category and vendor risk management, track vendor performance and compliance, providing actionable KPIs and reducing budget discrepancies with data-driven insights.
![](/wp-content/uploads/2024/12/coin-1.png)
Cost Savings and Efficiency Gains
Leverage benchmarking tools and automation to reduce clinical budgets by over 15%, maximizing ROI through time and cost savings.
![](/wp-content/uploads/2024/12/bonding-1.png)
Seamless System Integrations
Connect Clinical Maestro with legacy systems for seamless data flows, ensuring transparency and informed decision-making across all platforms.
![](/wp-content/uploads/2024/12/consulting.png)
Expert Consulting for Complex Implementations
Our experienced consulting partners handle large, complex implementations, delivering seamless process transformation and effective change management for optimal success.
CASE STUDY
Driving Efficiency and Savings in a Large Phase III Trial
![West-coast biotech does well!](https://strategikon.com/wp-content/uploads/2024/11/Case-Study-Driving-Speed-and-Negotiated-Savings-with-Clinical-Maestro-scaled.jpg)
West-coast biotech does well!
2X
Faster from RFP to final budget
4 months
less time to source study compared to traditional tools
$800k
saved by enabling effective negotiations
Clinical Maestro streamlined RFP processes, improved due diligence, and enhanced decision-making.
Clinical Maestro streamlined RFP processes, improved due diligence, and enhanced decision-making.
West-coast biotech does well!
2X
Faster from RFP to final budget
4 months
less time to source study compared to traditional tools
$800k
saved by enabling effective negotiations
![Mid-size Biopharma company](https://strategikon.com/wp-content/uploads/2024/11/Case-Study-Operational-Services_Evidence_Customer-Service-Excellence_COVID19-Delay--scaled.jpg)
Mid-size Biopharma company
0%
variance achieved between CRO bids and Clinical Maestro-generated budgets for Phase I vaccine
2.25%
variance delivered by Clinical Maestro’s advanced algorithms for Phase II
+/-1.5%
accuracy achieved through refinements in cost models
Clinical Maestro enabled a biotech to deliver precise vaccine trial budgets, achieving great results with refined cost models
Clinical Maestro enabled a biotech to deliver precise vaccine trial budgets, achieving great results with refined cost models
Mid-size Biopharma company
0%
variance achieved between CRO bids and Clinical Maestro-generated budgets for Phase I vaccine
2.25%
variance delivered by Clinical Maestro’s advanced algorithms for Phase II
+/-1.5%
accuracy achieved through refinements in cost models
![Leading Japanese Pharma Drives Budget Accuracy for Complex Oncology Study](https://strategikon.com/wp-content/uploads/2024/11/Case-Study-PORTFOLIO-Budgeting_Mid-Complexity-P1-Oncology-Study-scaled.jpg)
Leading Japanese Pharma Drives Budget Accuracy for Complex Oncology Study
3 hours
to build budgets and scenarios
12%
minimal variance between CRO bids and Clinical Maestro
4 scenarios
optimized for cost efficiency
PORTFOLIO enables accurate budgeting for high-complexity trials, reducing variances, enhancing efficiency, and optimizing CRO negotiations.
PORTFOLIO enables accurate budgeting for high-complexity trials, reducing variances, enhancing efficiency, and optimizing CRO negotiations.
Leading Japanese Pharma Drives Budget Accuracy for Complex Oncology Study
3 hours
to build budgets and scenarios
12%
minimal variance between CRO bids and Clinical Maestro
4 scenarios
optimized for cost efficiency
RESOURCES
Explore Expert Insights and Resources for Clinical Excellence
![Technology for Fast, Accurate Planning and Budgeting](https://strategikon.com/wp-content/uploads/2024/11/WEBINAR-Technology-for-fast-accurate-planning-and-budgeting-scaled.jpg)
Webinars
Technology for Fast, Accurate Planning and Budgeting
Leading biopharmaceutical sponsors trust PORTFOLIO for pipeline planning and budgeting with superior results and reported more than 10x Return on Investment.
![Driving Customer Success Through Governance: Transforming Pharma Vendor Management with AI Innovation](https://strategikon.com/wp-content/uploads/2025/01/BLOG-Driving-Customer-Success-Through-Governance-Transforming-Pharma-Vendor-Management-with-AI-Innovation.jpg)
Blogs
Driving Customer Success Through Governance: Transforming Pharma Vendor Management with AI Innovation
Effective vendor governance is essential to ensure operational success, cost efficiency, and regulatory compliance.
![Streamlining Vendor Management: How a Leading Biopharma Company Found Success](https://strategikon.com/wp-content/uploads/2025/01/Streamlining-Vendor-Management-How-a-Leading-Biopharma-Company-Found-Success-scaled-1.jpg)
Case Studies
Streamlining Vendor Management: How a Leading Biopharma Company Found Success
DEMO
Request a demo
Discover how Strategikon’s advanced solutions can streamline your clinical trial operations. Request a personalized demo to explore how our tools transform budgeting, vendor management, and outsourcing efficiency for pharma and biotech.